Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trump's Budget Surprise: FDA Gains 13% Increase

Executive Summary

President Trump's FY 2019 budget request includes $473m in new non-user fee revenue for the US agency, a reversal of the previous year's request.

Related Content

Orphan Drug Policy Changes To Be Considered Under US FDA's FY 2019 Budget Proposal
Gottlieb Showing Capitol Hill Skills With Funding Success
Gottlieb An Anchor For OTC Drug Industry On Stormy Congressional Seas
Drug Pricing Concerns May Hinder Rare Disease Lobbying Effort
Gottlieb's Priority For Proposed Opioid Money Is Mail Facilities
Trump's Budget Request To Include ANDA Exclusivity Changes
State Opioid Prescribing Databases Can Handle US FDA's Needs, Officials Say
Trump On Right-to-Try: Gottlieb's 'Heading It Up'?
Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling
FDA Safety Initiatives Could Suffer Under Trump's Budget Proposal





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts